Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial.
Marlow N, Stahl A, Lepore D, Fielder A, Reynolds JD, Zhu Q, Weisberger A, Stiehl DP, Fleck B; RAINBOW investigators group. Marlow N, et al. Among authors: fielder a. Lancet Child Adolesc Health. 2021 Oct;5(10):698-707. doi: 10.1016/S2352-4642(21)00195-4. Epub 2021 Aug 13. Lancet Child Adolesc Health. 2021. PMID: 34391532 Clinical Trial.
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial.
Fidler M, Fleck BW, Stahl A, Marlow N, Chastain JE, Li J, Lepore D, Reynolds JD, Chiang MF, Fielder AR; RAINBOW study group†. Fidler M, et al. Among authors: fielder ar. Transl Vis Sci Technol. 2020 Jul 29;9(8):43. doi: 10.1167/tvst.9.8.43. eCollection 2020 Jul. Transl Vis Sci Technol. 2020. PMID: 32855889 Free PMC article.
International Classification of Retinopathy of Prematurity, Third Edition.
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A Jr, Chen Y, Dai S, Ells A, Fleck BW, Good WV, Elizabeth Hartnett M, Holmstrom G, Kusaka S, Kychenthal A, Lepore D, Lorenz B, Martinez-Castellanos MA, Özdek Ş, Ademola-Popoola D, Reynolds JD, Shah PK, Shapiro M, Stahl A, Toth C, Vinekar A, Visser L, Wallace DK, Wu WC, Zhao P, Zin A. Chiang MF, et al. Among authors: fielder ar. Ophthalmology. 2021 Oct;128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031. Epub 2021 Jul 8. Ophthalmology. 2021. PMID: 34247850 Free PMC article. Review.
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial.
Fleck BW, Reynolds JD, Zhu Q, Lepore D, Marlow N, Stahl A, Li J, Weisberger A, Fielder AR; RAINBOW Investigator Group. Fleck BW, et al. Among authors: fielder ar. Ophthalmol Retina. 2022 Jul;6(7):628-637. doi: 10.1016/j.oret.2022.02.006. Epub 2022 Feb 22. Ophthalmol Retina. 2022. PMID: 35202890 Free article. Clinical Trial.
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis.
Campbell JP, Chiang MF, Chen JS, Moshfeghi DM, Nudleman E, Ruambivoonsuk P, Cherwek H, Cheung CY, Singh P, Kalpathy-Cramer J, Ostmo S, Eydelman M, Chan RVP, Capone A Jr; Collaborative Community in Ophthalmic Imaging Executive Committee and the Collaborative Community in Ophthalmic Imaging Retinopathy of Prematurity Workgroup. Campbell JP, et al. Ophthalmology. 2022 Jul;129(7):e69-e76. doi: 10.1016/j.ophtha.2022.02.008. Epub 2022 Feb 12. Ophthalmology. 2022. PMID: 35157950 Free PMC article.
Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.
Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer D, Tung B; CRYO-ROP and LIGHT-ROP Cooperative Study Groups. Reynolds JD, et al. Among authors: fielder ar. Arch Ophthalmol. 2002 Nov;120(11):1470-6. doi: 10.1001/archopht.120.11.1470. Arch Ophthalmol. 2002. PMID: 12427059
Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials.
Smith LEH, Hellström A, Stahl A, Fielder A, Chambers W, Moseley J, Toth C, Wallace D, Darlow BA, Aranda JV, Hallberg B, Davis JM; Retinopathy of Prematurity Workgroup of the International Neonatal Consortium. Smith LEH, et al. Among authors: fielder a. JAMA Ophthalmol. 2019 Mar 1;137(3):305-311. doi: 10.1001/jamaophthalmol.2018.5984. JAMA Ophthalmol. 2019. PMID: 30543348 Free PMC article.
311 results